How does mutation screening work as indirect evidence?
Our mutation tests provide a second, indirect layer. The logic is genetically sound:
A spontaneous mutation arises at one specific position in the genome, in a single individual, at some point in history. The chance that exactly the same mutation arises twice, independently, in two different species, at exactly the same spot in the gene, is extremely small.
Two concrete examples from our own data:
SL ino2.
This mutation occurs in both the Psittacula eupatria and the Psittacula krameri, at exactly the same position in the gene. Arising spontaneously and independently twice is genetically all but ruled out.
Far more likely: the mutation first arose in one species and then passed to the other through introgressive hybridisation. SL ino2 probably arose originally in the Psittacula krameri and later crept into the Psittacula eupatria, whether in captivity or in the wild. An Psittacula eupatria carrying SL ino2 is therefore very likely to have Psittacula krameri in its ancestry. You can read more about the SL ino mutations in our blog post on lutino.
Blue4 and blue5.
These two blue mutations are typical of the Psittacula krameri. When we nevertheless detect them in a Psittacula eupatria, this strongly points to crossing-in from the Psittacula krameri. We therefore screen Psittacula eupatria bloodlines first for blue1, blue2 and blue3. The presence of blue4 or blue5 in a bird kept as a Psittacula eupatria is in itself already a signal. More on the blue series in our blog post on blue, aqua and turquoise.
The nuance that goes with it
The absence of evidence is not the same as evidence of absence.
SL ino1, SL ino5, blue1, blue2 and blue3 we have so far confirmed exclusively in the Psittacula eupatria. That need not mean they have never arisen spontaneously in the Psittacula krameri, or were ever crossed in. At this point it only means: we have not yet picked them up there. Further research and broader sampling may adjust that picture in the future.